Accessibility Menu
China Resources Medical logo

China Resources Medical(SEHK) 1515

Market CapHK$3.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-67%
5 Year-63%
1 Year-32%
1 Month-1%
HK$2.49
-0.80%
-0.02Today
China Resources Medical last closing stock price
MetricPriceDate
Last closeHKD 2.512026-09-01
China Resources Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.91%HKD 2.582026-08-25
1 month-1.38%HKD 2.542026-07-31
3 month-4.75%HKD 2.632026-06-03
Year to date-21.96%HKD 3.212025-12-31
1 year-31.93%HKD 3.682025-09-01
3 year-56.96%HKD 5.822023-08-31
5 year-63.11%HKD 6.792021-09-02
Since inception-67.45%HKD 7.832013-11-29

China Resources Medical Financials at a Glance

Market Cap

HK$3.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥18.47B

Net Income (TTM)

CN¥889.12M

EPS (TTM)

HK$0.37

P/E Ratio

6.81

Dividend

HK$0.15

Beta (Volatility)

-0.07 (Low)

Price

HK$2.49

Volume

351,500

Open

HK$2.49

Previous Close

HK$2.51

Daily Range

HK$2.49 - HK$2.51

52-Week Range

HK$2.34 - HK$3.72

Estimated Earnings Date

Mar 30, 2027

1515 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About China Resources Medical

China Resources Medical Holdings Company Limited operates as an investment holding firm, delivering a wide range of healthcare services in the People's Republic of China. The company focuses on hospital administration, general medical care, and advisory functions, structured into three main divisions: owned hospitals, managed facilities, and ancillary operations.

Products and Services
  • Directly owned hospitals providing comprehensive medical care
  • Managed facilities under Invest-Operate-Transfer agreements
  • Group purchasing solutions and ancillary healthcare services
Growth Outlook
  • Healthcare sector growth in China projected to continue, driven by rising demand
  • Expansion of hospital network through strategic partnerships and acquisitions
  • Focus on operational efficiency to enhance profitability and service delivery
Financial Highlights
  • Recent quarterly revenue of 4.65 billion CNY, showing consistent growth
  • Trailing twelve months (TTM) net profit margin of 5.4%, indicating stable profitability
  • Dividend yield of approximately 5.97%, reflecting commitment to shareholder returns
China Resources Medical Holdings Company Limited is strategically positioned within the growing healthcare sector in China. The company's diversified operations, including hospital management and ancillary services, provide a robust foundation for future growth. Recent financial performance indicates a solid revenue stream and profitability, supported by a healthy dividend yield. The focus on expanding the hospital network and improving operational efficiency further enhances the company's potential for sustained growth. Investors may find the company's commitment to healthcare services and strategic initiatives appealing in the context of China's evolving healthcare landscape.
AI Generated • Aug 8, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

19,687

CEO

Chuang Zhang

Website

www.crmedical.hk

Headquarters

Beijing, BE 100069, CN

1515 Financials

Key Financial Metrics (TTM)

Gross Margin

16.95%

Operating Margin

6.08%

Net Income Margin

4.61%

Return on Equity

6.30%

Return on Capital

5.70%

Return on Assets

3.22%

Earnings Yield

14.68%

Dividend Yield

5.94%

Payout Ratio

39.29%

Stock Overview

Market Cap

HK$3.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.29B

Volume

351.50K

Avg. Volume

1.90M

Financials (TTM)

Gross Profit

CN¥3.02B

Operating Income

CN¥978.93M

EBITDA

CN¥2.08B

Operating Cash Flow

CN¥2.80B

Capital Expenditure

-CN¥1.09B

Free Cash Flow

CN¥1.71B

Cash & ST Invst.

CN¥1.08B

Total Debt

CN¥862.28M

China Resources Medical Performance Analysis

China Resources Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 9,188,234,38871.4%
20232023-12-31CNY 11,168,767,25721.6%
20242024-12-31CNY 10,684,798,281-4.3%
20252025-12-31CNY 9,951,201,444-6.9%
China Resources Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-2.0%
Q22025-06-30-7.2%
Q42025-12-312.8%
Q22026-06-30-5.0%
China Resources Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY 0.25-38.5%
20232023-12-31CNY 0.23-8.1%
20242024-12-31CNY 0.49115.5%
20252025-12-31CNY 0.43-12.3%
China Resources Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-70.6%
Q22025-06-30170.0%
Q42025-12-31-51.9%
Q22026-06-3061.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CN¥4.42B

-11.2%

Gross Profit

CN¥808.57M

-22.0%

Gross Margin

18.31%

N/A

Market Cap

HK$3.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

HK$166.87K

N/A

Employees

19,687

N/A

Net Income

CN¥261.25M

-39.8%

EBITDA

CN¥643.94M

-23.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CN¥1.08B

-16.5%

Total Debt

CN¥862.28M

-60.0%

Accounts Receivable

CN¥1.26B

-20.9%

Inventory

CN¥239.95M

-12.5%

Long Term Debt

CN¥119.94M

-93.0%

Short Term Debt

CN¥742.35M

+69.9%

Return on Assets

3.22%

N/A

Return on Invested Capital

6.30%

N/A

Free Cash Flow

CN¥620.59M

+71.6%

Operating Cash Flow

CN¥913.57M

+39.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About 1515

What is the current price of China Resources Medical?

China Resources Medical is trading at HK$2.49 per share.

What is the 52-week range for China Resources Medical?

Over the past 52 weeks, China Resources Medical has traded between HK$2.34 and HK$3.72.

How much debt does China Resources Medical have?

As of the most recent reporting period, China Resources Medical reported total debt of CN¥950.19M.

How much cash does China Resources Medical have on hand?

China Resources Medical reported CN¥1.15B in cash and cash equivalents in its most recent financial results.

What is China Resources Medical’s dividend yield?

China Resources Medical currently has a dividend yield of 5.94%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services